GI Innovation allergic diseases treatment
Scope
Date
~
-
Bio & Pharma
Celltrion to supply breast, stomach cancer treatment to Brazil
Celltrion Inc., South Korea’s largest biosimilar maker, announced on Friday that its breast and stomach cancer treatment "Herzuma" (active ing...
Sep 13, 2024 (Gmt+09:00)
-
Energy
Korea's SK Energy to start commercial operations of SAF production line
SK Energy Co., South Korea’s largest oil refiner, is set to start commercial operations of a production line for sustainable aviation fuel (SA...
Sep 11, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Group’s 3rd-generation daughter comes to the fore
Chey Yoon-chung, the eldest daughter of SK Group Chairman Chey Tae-won, unexpectedly made her debut during an SK Biopharmaceuticals Co. video confer...
Aug 30, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
SK Innovation-SK E&S merger gains shareholders’ nod
SK Innovation Co., South Korea’s largest energy company, has won majority support from its shareholders for a merger with its liquefied natura...
Aug 27, 2024 (Gmt+09:00)
-
Pension funds
NPS to veto SK Innovation’s merger with LNG affiliate
South Korea’s National Pension Service (NPS), manager of the world’s third-largest public pension fund, said on Thursday it is set to ve...
Aug 23, 2024 (Gmt+09:00)
-
Korean stock market
Korea's KEDI-based ETFs boom; net assets double in 2 months
South Korean exchange-traded funds (ETFs) tracking KEDI, an index set created by The Korea Economic Daily, are booming on growing investor demand fo...
Aug 20, 2024 (Gmt+09:00)
-
Bio & Pharma
IMBiologics transfers autoimmune disease drug tech to Huadong Pharma
South Korea's antibody-based biotech company IMBiologics announced on Friday that it signed a contract to transfer the technology of its autoimmune ...
Aug 16, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
GS E&C in talks to sell entire stake in GS Elevator to Chinese firm
South Korea’s GS Engineering & Construction Corp. (GS E&C) is in talks to sell its entire stake in GS Elevator Co. to a Chinese strate...
Aug 14, 2024 (Gmt+09:00)
-
Bio & Pharma
Costco sells Celltrion's Yuflyma Low WAC in US
South Korea's Celltrion Inc. announced on Tuesday that its autoimmune disease treatment Yuflyma (Low WAC, active ingredient adalimumab) is now avail...
Aug 13, 2024 (Gmt+09:00)
-
Automobiles
The new Kia K8: A high-tech, modern and innovative sedan
South Korea’s second-largest automaker Kia Corp. on Friday unveiled a new K8 large-size sedan, its first drastic facelift in three years.Kia, ...
Aug 09, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets approval of Steqeyma in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Steqeyma, a biosimilar of the autoimmune dise...
Jul 31, 2024 (Gmt+09:00)
-
Corporate strategy
Lotte leader Shin Dong-bin stresses pivot to AI-centered innovation
Shin Dong-bin, chairman of South Korea’s retail, food and chemicals conglomerate Lotte, on Friday urged affiliate executives to ramp up effort...
Jul 19, 2024 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma sells HK subsidiary to CR Pharm Group for $254 mn
South Korea’s GC Biopharma Corp. announced on Wednesday that it signed a share purchase agreement (SPA) to sell all its shares in its Hong Kon...
Jul 18, 2024 (Gmt+09:00)
-
Corporate restructuring
SK Innovation to be Asia’s top energy company through merger
SK Innovation Co., South Korea’s largest energy company, is set to become the industry leader in Asia through a merger with an affiliate while...
Jul 17, 2024 (Gmt+09:00)
-
Corporate restructuring
SK Ecoplant to merge tech unit for group restructuring
SK Ecoplant Co., a South Korean construction engineering and waste management company, is set to merge a profit-making technology subsidiary of the ...
Jul 16, 2024 (Gmt+09:00)
-
Robotics
Lotte Innovate releases autonomous security robot Dooroo Eye
South Korea's Lotte Innovate will unveil its autonomous security robot, Dooroo Eye, at the upcoming Autonomous Driving Mobility EXPO 2024, the com...
Jul 16, 2024 (Gmt+09:00)
-
Batteries
SK Innovation to host Global Forum in US
South Korea's SK Innovation Co. announced on Wednesday that it will host the “SK Innovation Global Forum” on July 13 in San Jose, Califo...
Jul 10, 2024 (Gmt+09:00)
-
ESG
SK Innovation gets MSCI ESG's leader rating
South Korean oil refiner SK Innovation Co. secured an AA rating in the environmental, social, and governance (ESG) assessment by Morgan Stanley Capi...
Jul 08, 2024 (Gmt+09:00)
-
Batteries
Time to revive innovator spirit: LG Energy Solution CEO
South Korea’s top battery maker LG Energy Solution Ltd., also the world’s No. 3, must accelerate innovation and prop up fundamentals to ...
Jul 04, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem launches Synovian in China
South Korea's LG Chem Ltd. announced on Wednesday that it launched its homegrown new drug for osteoarthritis Synovian (marketed in China as Hyruan O...
Jul 03, 2024 (Gmt+09:00)
-
Korean startups
SK Innovation-backed Marine Innovation looks to enter US green market
Marine Innovation Co., a South Korean eco-friendly social venture company sponsored by the country’s top energy firm SK Innovation Co., is par...
Jun 25, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
SK Innovation looks to merge with SK E&S for organic growth
SK Innovation Co., the parent of South Korea’s largest oil refiner SK Energy Co. and battery maker SK On Co., is looking to merge with energy ...
Jun 20, 2024 (Gmt+09:00)
-
Beauty & Cosmetics
L'Oréal to nurture K-Beauty startups
L'Oréal, the world's largest cosmetics group, announced on Wednesday that it is recruiting digital and innovative technology companies to p...
Jun 13, 2024 (Gmt+09:00)
-
Corporate strategy
SK Innovation’s Ulsan plant goes smarter with AI, robot dog, AR tech
ULSAN, South Gyeongsang Province – At a petrochemical plant run by SK Innovation Co., South Korea’s largest oil refiner, Spot, a robot d...
May 26, 2024 (Gmt+09:00)
-
Bio & Pharma
Handok gets Biocon's obesity drug exclusive distribution in S.Korea
South Korean pharmaceutical company Handok Inc. announced on Friday that it signed an exclusive domestic sales and distribution agreement with India...
May 24, 2024 (Gmt+09:00)
-
Bio & Pharma
Investors dump Korean biotech HLB stocks on FDA rejection
HLB Co. and its affiliate stocks tumbled on Friday on news that the South Korean biotech group’s highly anticipated new cancer treatment Rivoc...
May 17, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply Remsima, Herzuma to Peru
South Korea's Celltrion Inc. announced on Thursday that it secured a contract to supply its biosimilars for autoimmune disease treatment and antican...
May 02, 2024 (Gmt+09:00)
-
Artificial intelligence
S.Korea’s KT to innovate media, content businesses with AI
South Korea’s telecom giant KT Corp. is set to innovate its media and content businesses with artificial intelligence as it seeks new growth d...
Apr 29, 2024 (Gmt+09:00)
-
Korean startups
Bet on innovations with societal impact: Kakao Ventures CEO
In the past 10 years, Kim Ki-jun has been on the hunt for deep technology startups that will have a significant societal impact, and he will continu...
Apr 24, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis gets OK to sell Stelara biosimilar in Europe
South Korea's Samsung Bioepis has received approval from the European Commission to sell Pyzchiva, a biosimilar of the autoimmune disease Stelara.&n...
Apr 23, 2024 (Gmt+09:00)